ERIC BJERKHOLT
CIK 1197350 · CHIEF FINANCIAL OFFICER · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.36M
Companies
13
Total Filings
117
Lifetime Open-Market Net
-$1.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGX | Director | — | $1.20 | — | $0 | 3 | 2026-06-11 |
| CERS | Director | 261,679 | $2.56 | $669.9K | $37.5K | 17 | 2026-06-11 |
| MIRM | CHIEF FINANCIAL OFFICER | 47,181 | $99.34 | $4.69M | -$1.70M | 16 | 2026-06-09 |
| SRZNW | Director | — | $0.02 | — | $0 | 4 | 2026-05-14 |
| CalciMedica, Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 1 | 2024-08-28 |
| CALC | Director | 3,534 | $0.87 | $3.1K | $6.7K | 7 | 2024-04-22 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Chief Financial Officer | 0 | $40.39 | $0 | -$231.7K | 9 | 2023-08-11 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| COLL | Chief Financial Officer | 0 | $34.64 | $0 | $316.9K | 15 | 2020-10-14 |
| Corium International, Inc. (CORI) Delisted | Director | 0 | — | — | $89.2K | 6 | 2018-11-28 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | EVP, CFO & Corp. Secretary | 37,388 | $18.62 | $696.2K | $20.2K | 23 | 2016-12-06 |
| STEM | Director | 273,759 | $7.31 | $2.00M | $0 | 12 | 2016-01-05 |
| Viracta Therapeutics, Inc. (SNSSD) Delisted | Sr. VP, CFO & Corp. Secretary | 84,582 | — | — | $0 | 1 | 2011-03-02 |
Recent Filings · Page 4 of 12
117 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-23 | CERS | Buy (P) | +10,000 | $17.2K | EDGAR |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Disp (D) | −39,371 | $0 | EDGAR |
| 2023-06-28 | CALC | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | CERS | Grant (A) | +40,000 | $200.0K | EDGAR |
| 2023-06-01 | CALC | Buy (P) | +255 | $1.1K | EDGAR |
| 2023-05-24 | CALC | Buy (P) | +500 | $1.6K | EDGAR |
| 2023-05-23 | CERS | Buy (P) | +5,000 | $10.0K | EDGAR |
| 2023-05-22 | CALC | Buy (P) | +200 | $530 | EDGAR |
| 2023-05-19 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2023-05-18 | CALC | Buy (P) | +1,300 | $3.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.